Functional abrogation of p53 is required for T-Ag induced proliferation in cardiomyocytes

Nam Eung Huh, Kishore B.S. Pasumarthi, Mark H. Soonpaa, Shaoliang Jing, Brian Patton, Loren J. Field

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Targeted expression of the SV40 large T-antigen oncoprotein (T-Ag) induces cardiomyocyte proliferation in the atria and ventricles of transgenic mice. Previous studies have identified the p53 tumor suppressor, p107 (a homologue of the retinoblastoma tumor suppressor), and p193 (a novel BH3 only proapoptosis protein) as prominent T-Ag binding proteins in cardiomyocyte cell lines derived from these transgenic mice. To further explore the significance of these protein-protein interactions in the regulation of cardiomyocyte proliferation, a transgene comprising the human atrial natriuretic factor (ANF) promoter and sequences encoding a mutant T-Ag lacking the p53 binding domain was generated. Repeated micro-injection of this DNA gave rise to genetically mosaic animals with minimal transgene content, suggesting that widespread cardiac expression of mutant T-Ag was deleterious. This notion was supported by the observation that the transgene was selectively lost from the cardiac myocytes (but not the cardiac fibroblasts) in the mosaic animals. Crosses between the mosaic mice and animals expressing a cardiac restricted dominant negative p53 resulted in transgene transmission with ensuing overt cardiac tumorigenesis. Transfection of the mutant T-Ag in embryonic stem (ES) cell-derived cardiomyocytes resulted in wide-spread cell death with characteristics typical of apoptosis. Co-transfection with a dominant negative p53 transgene rescued mutant T-Ag-induced cell death in the ES-derived cardiomyocyte cultures, resulting in a marked proliferative response similar to that seen in vivo with the rescued transgenic mouse study. These results indicate that T-Ag expression in the absence of p53 functional abrogation results in cardiomyocyte death.

Original languageEnglish (US)
Pages (from-to)1405-1419
Number of pages15
JournalJournal of Molecular and Cellular Cardiology
Volume33
Issue number8
DOIs
StatePublished - Jan 1 2001

Fingerprint

Oncogene Proteins
Viral Tumor Antigens
Cardiac Myocytes
Transgenes
Transgenic Mice
Transfection
Cell Death
Polyomavirus Transforming Antigens
Tumor Suppressor Protein p53
Proteins
Retinoblastoma
Atrial Natriuretic Factor
Embryonic Stem Cells
Neoplasms
Carrier Proteins
Carcinogenesis
Fibroblasts
Apoptosis
Cell Line
Injections

Keywords

  • Cardiac regeneration
  • Cardiomyocyte terminal differentiation
  • Myocardial apoptosis

ASJC Scopus subject areas

  • Molecular Biology
  • Cardiology and Cardiovascular Medicine

Cite this

Functional abrogation of p53 is required for T-Ag induced proliferation in cardiomyocytes. / Huh, Nam Eung; Pasumarthi, Kishore B.S.; Soonpaa, Mark H.; Jing, Shaoliang; Patton, Brian; Field, Loren J.

In: Journal of Molecular and Cellular Cardiology, Vol. 33, No. 8, 01.01.2001, p. 1405-1419.

Research output: Contribution to journalArticle

Huh, Nam Eung ; Pasumarthi, Kishore B.S. ; Soonpaa, Mark H. ; Jing, Shaoliang ; Patton, Brian ; Field, Loren J. / Functional abrogation of p53 is required for T-Ag induced proliferation in cardiomyocytes. In: Journal of Molecular and Cellular Cardiology. 2001 ; Vol. 33, No. 8. pp. 1405-1419.
@article{dead5123a1bc4055933196f30220df0b,
title = "Functional abrogation of p53 is required for T-Ag induced proliferation in cardiomyocytes",
abstract = "Targeted expression of the SV40 large T-antigen oncoprotein (T-Ag) induces cardiomyocyte proliferation in the atria and ventricles of transgenic mice. Previous studies have identified the p53 tumor suppressor, p107 (a homologue of the retinoblastoma tumor suppressor), and p193 (a novel BH3 only proapoptosis protein) as prominent T-Ag binding proteins in cardiomyocyte cell lines derived from these transgenic mice. To further explore the significance of these protein-protein interactions in the regulation of cardiomyocyte proliferation, a transgene comprising the human atrial natriuretic factor (ANF) promoter and sequences encoding a mutant T-Ag lacking the p53 binding domain was generated. Repeated micro-injection of this DNA gave rise to genetically mosaic animals with minimal transgene content, suggesting that widespread cardiac expression of mutant T-Ag was deleterious. This notion was supported by the observation that the transgene was selectively lost from the cardiac myocytes (but not the cardiac fibroblasts) in the mosaic animals. Crosses between the mosaic mice and animals expressing a cardiac restricted dominant negative p53 resulted in transgene transmission with ensuing overt cardiac tumorigenesis. Transfection of the mutant T-Ag in embryonic stem (ES) cell-derived cardiomyocytes resulted in wide-spread cell death with characteristics typical of apoptosis. Co-transfection with a dominant negative p53 transgene rescued mutant T-Ag-induced cell death in the ES-derived cardiomyocyte cultures, resulting in a marked proliferative response similar to that seen in vivo with the rescued transgenic mouse study. These results indicate that T-Ag expression in the absence of p53 functional abrogation results in cardiomyocyte death.",
keywords = "Cardiac regeneration, Cardiomyocyte terminal differentiation, Myocardial apoptosis",
author = "Huh, {Nam Eung} and Pasumarthi, {Kishore B.S.} and Soonpaa, {Mark H.} and Shaoliang Jing and Brian Patton and Field, {Loren J.}",
year = "2001",
month = "1",
day = "1",
doi = "10.1006/jmcc.2001.1403",
language = "English (US)",
volume = "33",
pages = "1405--1419",
journal = "Journal of Molecular and Cellular Cardiology",
issn = "0022-2828",
publisher = "Academic Press Inc.",
number = "8",

}

TY - JOUR

T1 - Functional abrogation of p53 is required for T-Ag induced proliferation in cardiomyocytes

AU - Huh, Nam Eung

AU - Pasumarthi, Kishore B.S.

AU - Soonpaa, Mark H.

AU - Jing, Shaoliang

AU - Patton, Brian

AU - Field, Loren J.

PY - 2001/1/1

Y1 - 2001/1/1

N2 - Targeted expression of the SV40 large T-antigen oncoprotein (T-Ag) induces cardiomyocyte proliferation in the atria and ventricles of transgenic mice. Previous studies have identified the p53 tumor suppressor, p107 (a homologue of the retinoblastoma tumor suppressor), and p193 (a novel BH3 only proapoptosis protein) as prominent T-Ag binding proteins in cardiomyocyte cell lines derived from these transgenic mice. To further explore the significance of these protein-protein interactions in the regulation of cardiomyocyte proliferation, a transgene comprising the human atrial natriuretic factor (ANF) promoter and sequences encoding a mutant T-Ag lacking the p53 binding domain was generated. Repeated micro-injection of this DNA gave rise to genetically mosaic animals with minimal transgene content, suggesting that widespread cardiac expression of mutant T-Ag was deleterious. This notion was supported by the observation that the transgene was selectively lost from the cardiac myocytes (but not the cardiac fibroblasts) in the mosaic animals. Crosses between the mosaic mice and animals expressing a cardiac restricted dominant negative p53 resulted in transgene transmission with ensuing overt cardiac tumorigenesis. Transfection of the mutant T-Ag in embryonic stem (ES) cell-derived cardiomyocytes resulted in wide-spread cell death with characteristics typical of apoptosis. Co-transfection with a dominant negative p53 transgene rescued mutant T-Ag-induced cell death in the ES-derived cardiomyocyte cultures, resulting in a marked proliferative response similar to that seen in vivo with the rescued transgenic mouse study. These results indicate that T-Ag expression in the absence of p53 functional abrogation results in cardiomyocyte death.

AB - Targeted expression of the SV40 large T-antigen oncoprotein (T-Ag) induces cardiomyocyte proliferation in the atria and ventricles of transgenic mice. Previous studies have identified the p53 tumor suppressor, p107 (a homologue of the retinoblastoma tumor suppressor), and p193 (a novel BH3 only proapoptosis protein) as prominent T-Ag binding proteins in cardiomyocyte cell lines derived from these transgenic mice. To further explore the significance of these protein-protein interactions in the regulation of cardiomyocyte proliferation, a transgene comprising the human atrial natriuretic factor (ANF) promoter and sequences encoding a mutant T-Ag lacking the p53 binding domain was generated. Repeated micro-injection of this DNA gave rise to genetically mosaic animals with minimal transgene content, suggesting that widespread cardiac expression of mutant T-Ag was deleterious. This notion was supported by the observation that the transgene was selectively lost from the cardiac myocytes (but not the cardiac fibroblasts) in the mosaic animals. Crosses between the mosaic mice and animals expressing a cardiac restricted dominant negative p53 resulted in transgene transmission with ensuing overt cardiac tumorigenesis. Transfection of the mutant T-Ag in embryonic stem (ES) cell-derived cardiomyocytes resulted in wide-spread cell death with characteristics typical of apoptosis. Co-transfection with a dominant negative p53 transgene rescued mutant T-Ag-induced cell death in the ES-derived cardiomyocyte cultures, resulting in a marked proliferative response similar to that seen in vivo with the rescued transgenic mouse study. These results indicate that T-Ag expression in the absence of p53 functional abrogation results in cardiomyocyte death.

KW - Cardiac regeneration

KW - Cardiomyocyte terminal differentiation

KW - Myocardial apoptosis

UR - http://www.scopus.com/inward/record.url?scp=0034918784&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034918784&partnerID=8YFLogxK

U2 - 10.1006/jmcc.2001.1403

DO - 10.1006/jmcc.2001.1403

M3 - Article

C2 - 11448130

AN - SCOPUS:0034918784

VL - 33

SP - 1405

EP - 1419

JO - Journal of Molecular and Cellular Cardiology

JF - Journal of Molecular and Cellular Cardiology

SN - 0022-2828

IS - 8

ER -